San Bruno, CA, United States of America

Cedric Dos Santos

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Janssen Biotech, Inc.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cedric Dos Santos. Retrieved from https://idiyas.com/inventor/cedric-dos-santos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Cedric Dos Santos: Innovator in Cancer Treatment

Introduction

Cedric Dos Santos is a notable inventor based in San Bruno, CA, who has made significant contributions to the field of cancer treatment. With a focus on innovative therapies, he has developed methods that aim to improve patient outcomes in acute myeloid leukemia.

Latest Patents

Cedric holds 2 patents related to his groundbreaking work. His latest patents include methods of treatment for acute myeloid leukemia using anti-CD38 antibodies. These inventions represent a promising advancement in the fight against this aggressive form of cancer.

Career Highlights

Cedric is currently employed at Janssen Biotech, Inc., where he continues to push the boundaries of medical research and innovation. His work is characterized by a commitment to developing effective treatments that can significantly impact patient care.

Collaborations

Throughout his career, Cedric has collaborated with talented professionals, including Parul Doshi and Gwenn Danet-Desnoyers. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic strategies.

Conclusion

Cedric Dos Santos is a dedicated inventor whose work in cancer treatment exemplifies the importance of innovation in medicine. His contributions are paving the way for new therapies that could change the lives of many patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…